Euthymics Bioscience, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2017-06-01. The offering totals $500K, of which $300K was reported sold. Industry: Biotechnology.
Showing 25 of 26 people.
| Name | Role | Location |
|---|---|---|
| Jeffrey Bailey | Director | Wolfeboro, NH |
| Timothy Barberich | Director | Edina, MN |
| Anthony McKinney | Director | Cambridge, MA |
| Campbell Murray | Director | NOVATO, CA |
| Daniel Omstead | Director | Boston, MA |
| Brigitte Smith | Director | Melbourne, C3 |
| Paul Weiss | Director | Milwaukee, WI |
| Anthony McKinney | Executive Officer | Cambridge, MA |
| William Pappafotopoulos | Executive Officer | Cambridge, MA |
| Albert L Sokol | Executive Officer | Boston, MA |
| Timothy J Barberich | Director | Woburn, MA |
| Campbell A Murray | Director | Malvern, PA |
| Anthony A McKinney | Director | Cambridge, MA |
| Anthony A McKinney | Executive Officer | Cambridge, MA |
| Paul A Weiss | Director | Madison, WI |
| Douglas A Branch | Executive Officer | OKLAHOMA CITY, OK |
| Campbell P Murray | Director | Cambridge, MA |
| Franklin P Bymaster | Executive Officer | Brownsburg, IN |
| Paul P Weiss | Director | Madison, WI |
| Joshua P Funder | Director | Melbourne VIC, C3 |
| Frank P Gentile | Director | Boston, MA |
| Thomas A Shea | Executive Officer | Cambridge, MA |
| Pierre J Tran | Executive Officer | Cambridge, MA |
| Andrew P Baker | Director | Melbourne VIC, C3 |
| Frank A Gentile | Director | Boston, MA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2012-11-27 | D | $6.0M | $3.0M |
| 2012-05-30 | D/A | $28.0M | $28.0M |
| 2012-03-16 | D/A | $28.0M | $24.3M |
| 2011-03-17 | D/A | $28.4M | $22.4M |
| 2010-07-29 | D | $24.2M | $5.2M |